V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280003716 | 280002757 | 1.7 | 52.1 | Curative (C) | 2017-02-21 | 2017-02-25 | Cisplatin +Fluorouracil (3 wk) | 02 | null | 280026026 | CISPLATIN + FLUOROURACIL |
| 280003717 | 280002757 | 1.83 | null | Curative (C) | 2015-04-10 | 2015-04-27 | Cetuximab + Radiotherapy Load | null | Y | 280026026 | CETUXIMAB + RT |
| 280003718 | 280002758 | 1.53 | null | Neo-adjuvant (N) | 2016-03-02 | 2016-04-11 | CISPLATIN + FLUOROURACIL | N | N | 280026030 | CISPLATIN + FLUOROURACIL |
| 280003719 | 280002759 | 1.5 | 96 | Neo-adjuvant (N) | null | 2014-07-07 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280026032 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003720 | 280002760 | 1.8 | 94.5 | Not known (9) | 2014-04-10 | 2014-04-24 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280026033 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003721 | 280002761 | 1.72 | null | Neo-adjuvant (N) | null | 2016-06-07 | Doxorubicin + Ifosfamide | N | N | 280026034 | DOXORUBICIN + IFOSFAMIDE |
| 280003722 | 280002762 | 1.76 | null | Neo-adjuvant (N) | 2013-11-03 | 2013-11-23 | Cisplatin + Docetaxel +Fluorouracil | null | null | 280026037 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003723 | 280002763 | 1.7 | 130 | Disease modification (D) | 2013-12-27 | 2014-01-01 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280026039 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003724 | 280002764 | null | 72 | Neo-adjuvant (N) | null | 2014-07-28 | Cisplatin +Fluorouracil (3 wk) | null | null | 280026040 | CISPLATIN + FLUOROURACIL |
| 280003725 | 280002765 | 1.7 | 78.7 | Neo-adjuvant (N) | 2015-07-26 | 2015-08-07 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 280026042 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003726 | 280002766 | 1.88 | 81.9 | Neo-adjuvant (N) | 2016-02-20 | 2016-02-24 | CISPLATIN + FLUOROURACIL | 2 | N | 280026043 | CISPLATIN + FLUOROURACIL |
| 280003727 | 280002767 | 1.61 | 107.4 | Curative (C) | 2014-08-10 | 2014-08-21 | CETUXIMAB + RT | 02 | Y | 280026044 | CETUXIMAB + RT |
| 280003728 | 280002768 | 1.72 | null | Curative (C) | 2018-01-20 | 2018-01-20 | Cetuximab + Radiotherapy Load | N | Y | 280026045 | CETUXIMAB + RT |
| 280003729 | 280002769 | 1.51 | 50.6 | Neo-adjuvant (N) | 2018-09-05 | 2018-09-07 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280026046 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003730 | 280002770 | 1.8 | 98.2 | Neo-adjuvant (N) | 2015-11-23 | 2015-11-30 | Cisplatin +Fluorouracil (3 wk) | 02 | null | 280026048 | CISPLATIN + FLUOROURACIL |
| 280003731 | 280002771 | 1.7 | 34.6 | Palliative (P) | 2013-12-03 | 2013-12-22 | Doxorubicin + Ifosfamide | N | N | 280026054 | DOXORUBICIN + IFOSFAMIDE |
| 280003732 | 280002772 | 1.76 | 75.5 | Neo-adjuvant (N) | 2015-05-04 | 2015-05-08 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | null | 280026055 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003733 | 280002773 | 1.8 | 91.9 | Neo-adjuvant (N) | 2016-06-19 | 2016-06-25 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280026058 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003734 | 280002774 | 1.84 | 94 | Curative (C) | 2015-02-10 | 2015-02-10 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280026059 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003735 | 280002774 | 1.63 | 102.8 | Neo-adjuvant (N) | 2013-09-06 | 2013-09-13 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280026059 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003736 | 280002774 | 1.87 | 152.2 | Neo-adjuvant (N) | null | 2017-04-01 | DOXORUBICIN + IFOSFAMIDE | N | N | 280026059 | DOXORUBICIN + IFOSFAMIDE |
| 280003737 | 280002775 | 1.7 | 78.3 | null | 2017-03-29 | 2017-03-29 | CISPLATIN + FLUOROURACIL | 02 | null | 280026065 | CISPLATIN + FLUOROURACIL |
| 280003738 | 280002776 | 1.82 | 73.6 | Neo-adjuvant (N) | null | 2013-12-14 | CISPLATIN + FLUOROURACIL | N | N | 280026067 | CISPLATIN + FLUOROURACIL |
| 280003739 | 280002777 | 1.81 | 63 | Curative (C) | null | 2016-05-13 | CETUXIMAB + RT | N | Y | 280026068 | CETUXIMAB + RT |
| 280003740 | 280002778 | 1.81 | 83.9 | Neo-adjuvant (N) | 2015-03-13 | 2015-03-16 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280026069 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003741 | 280002779 | 1.72 | 76 | Not known (9) | 2018-04-01 | 2018-04-18 | DOXORUBICIN + IFOSFAMIDE | 02 | N | 280026070 | DOXORUBICIN + IFOSFAMIDE |
| 280003742 | 280002780 | null | null | Neo-adjuvant (N) | 2017-05-04 | 2017-05-04 | CISPLATIN + FLUOROURACIL | N | N | 280026071 | CISPLATIN + FLUOROURACIL |
| 280003743 | 280002781 | 1.75 | 54 | Palliative (P) | 2017-10-09 | 2017-11-09 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 280026074 | CISPLATIN + FLUOROURACIL |
| 280003744 | 280007359 | 1.83 | 89 | Neo-adjuvant (N) | null | 2017-01-31 | DOXORUBICIN + IFOSFAMIDE | N | N | 280026078 | DOXORUBICIN + IFOSFAMIDE |
| 280003745 | 280002782 | 0 | 56.3 | null | 2017-11-29 | 2017-12-06 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 280026080 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003746 | 280007360 | 1.71 | 115.8 | Neo-adjuvant (N) | null | 2013-03-04 | Cisplatin +Fluorouracil (3 wk) | N | N | 280026081 | CISPLATIN + FLUOROURACIL |
| 280003747 | 280002783 | 1.69 | 77.4 | Neo-adjuvant (N) | 2016-04-25 | 2016-05-06 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 280026082 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003748 | 280002784 | 1.6 | 64.2 | null | 2014-01-03 | 2014-01-03 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280026083 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003749 | 280002785 | 1.88 | 68.9 | null | 2016-11-23 | 2016-11-27 | DOXORUBICIN + IFOSFAMIDE | 02 | null | 280026086 | DOXORUBICIN + IFOSFAMIDE |
| 280003750 | 280002786 | 1.54 | 88.1 | Neo-adjuvant (N) | 2015-11-30 | 2015-11-30 | Doxorubicin + Ifosfamide | 02 | N | 280026087 | DOXORUBICIN + IFOSFAMIDE |
| 280003751 | 280002786 | null | 88.2 | Neo-adjuvant (N) | 2016-10-03 | 2016-11-11 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280026087 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003752 | 280002786 | 1.67 | 79.5 | Neo-adjuvant (N) | 2014-09-10 | 2014-09-10 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | null | 280026087 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003753 | 280002787 | 1.8 | 54.5 | Neo-adjuvant (N) | null | 2016-05-01 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280026092 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003754 | 280002788 | 1.8 | 100 | Palliative (P) | 2017-04-05 | 2017-04-22 | Doxorubicin + Ifosfamide | 02 | N | 280026093 | DOXORUBICIN + IFOSFAMIDE |
| 280003755 | 280002788 | 1.8 | 82.9 | Neo-adjuvant (N) | 2015-05-27 | 2015-06-06 | Doxorubicin + Ifosfamide | 2 | N | 280026093 | DOXORUBICIN + IFOSFAMIDE |
| 280003756 | 280009756 | null | null | Adjuvant (A) | 2016-04-21 | 2016-04-30 | Doxorubicin + Ifosfamide | N | N | 280026098 | DOXORUBICIN + IFOSFAMIDE |
| 280003757 | 280009756 | 1.69 | null | Neo-adjuvant (N) | 2018-01-05 | 2018-01-20 | Cisplatin + Docetaxel +Fluorouracil | null | N | 280026098 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003758 | 280002789 | null | 86.4 | Neo-adjuvant (N) | null | 2013-10-23 | Cetuximab + Radiotherapy Load | null | Y | 280026102 | CETUXIMAB + RT |
| 280003759 | 280002789 | 1.67 | 88.9 | Curative (C) | 2016-01-01 | 2016-01-01 | Cetuximab + Radiotherapy Maint | 02 | N | 280026102 | CETUXIMAB + RT |
| 280003760 | 280009757 | 1.69 | 65.25 | Neo-adjuvant (N) | 2017-03-08 | 2017-03-09 | Doxorubicin + Ifosfamide | null | null | 280026104 | DOXORUBICIN + IFOSFAMIDE |
| 280003761 | 280002790 | 1.74 | 76.4 | Neo-adjuvant (N) | 2013-12-24 | 2014-01-06 | Doxorubicin + Ifosfamide | N | N | 280026106 | DOXORUBICIN + IFOSFAMIDE |
| 280003762 | 280002791 | 1.83 | 63.1 | Curative (C) | 2015-11-16 | 2015-12-07 | Cisplatin +Fluorouracil (3 wk) | N | Y | 280026109 | CISPLATIN + FLUOROURACIL |
| 280003763 | 280002791 | 1.75 | 87.4 | Neo-adjuvant (N) | 2017-03-02 | 2017-03-03 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 280026109 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003764 | 280002791 | 1.61 | 86.4 | Neo-adjuvant (N) | 2014-10-15 | 2014-10-23 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 280026109 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003765 | 280002792 | null | null | Curative (C) | 2015-06-18 | 2015-07-07 | Doxorubicin + Ifosfamide | N | N | 280026113 | DOXORUBICIN + IFOSFAMIDE |